🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.70
+0.44 (7.03%)
At close: Nov 18, 2026, 4:00 PM EST
6.70
0.00 (0.00%)
Pre-market: Nov 19, 2026, 8:37 AM EST

ImmunityBio Statistics

Total Valuation

ImmunityBio has a market cap or net worth of $7.13 billion. The enterprise value is $8.09 billion.

Market Cap7.13B
Enterprise Value 8.09B

Important Dates

The last earnings date was Monday, November 9, 2026, before market open.

Earnings Date Nov 9, 2026
Ex-Dividend Date n/a

Share Statistics

ImmunityBio has 1.06 billion shares outstanding. The number of shares has increased by 20.61% in one year.

Current Share Class 1.06B
Shares Outstanding 1.06B
Shares Change (YoY) +20.61%
Shares Change (QoQ) +1.03%
Owned by Insiders (%) 27.79%
Owned by Institutions (%) 20.28%
Float 410.68M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 39.04
Forward PS 23.30
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 44.31
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.27

Current Ratio 4.27
Quick Ratio 3.96
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.31

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -30.37%
Return on Invested Capital (ROIC) -70.52%
Return on Capital Employed (ROCE) -53.62%
Weighted Average Cost of Capital (WACC) 5.52%
Revenue Per Employee $264,214
Profits Per Employee -$1.61M
Employee Count691
Asset Turnover 0.32
Inventory Turnover 0.66

Taxes

Income Tax -126,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +230.05% in the last 52 weeks. The beta is 0.17, so ImmunityBio's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change +230.05%
50-Day Moving Average 8.48
200-Day Moving Average 7.97
Relative Strength Index (RSI) 40.71
Average Volume (20 Days) 13,087,065

Short Selling Information

The latest short interest is 126.08 million, so 11.85% of the outstanding shares have been sold short.

Short Interest 126.08M
Short Previous Month 122.95M
Short % of Shares Out 11.85%
Short % of Float 30.70%
Short Ratio (days to cover) 8.32

Income Statement

In the last 12 months, ImmunityBio had revenue of $182.57 million and -$1.11 billion in losses. Loss per share was -$1.08.

Revenue182.57M
Gross Profit 180.36M
Operating Income -274.16M
Pretax Income -1.11B
Net Income -1.11B
EBITDA -257.72M
EBIT -274.16M
Loss Per Share -$1.08
Full Income Statement

Balance Sheet

The company has $334.33 million in cash and $1.30 billion in debt, with a net cash position of -$961.77 million or -$0.90 per share.

Cash & Cash Equivalents 334.33M
Total Debt 1.30B
Net Cash -961.77M
Net Cash Per Share -$0.90
Equity (Book Value) -1.15B
Book Value Per Share -1.08
Working Capital 320.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$287.56 million and capital expenditures -$9.12 million, giving a free cash flow of -$296.69 million.

Operating Cash Flow -287.56M
Capital Expenditures -9.12M
Depreciation & Amortization 16.44M
Net Borrowing 78.01M
Free Cash Flow -296.69M
FCF Per Share -$0.28
Full Cash Flow Statement

Margins

Gross Margin 98.79%
Operating Margin -150.16%
Pretax Margin -607.89%
Profit Margin n/a
EBITDA Margin -141.16%
EBIT Margin -150.16%
FCF Margin n/a

Dividends & Yields

ImmunityBio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -20.61%
Shareholder Yield -20.61%
Earnings Yield -16.05%
FCF Yield -4.16%

Analyst Forecast

The average price target for ImmunityBio is $14.25, which is 112.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.25
Price Target Difference 112.69%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) 124.51%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ImmunityBio has an Altman Z-Score of -9.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -9.35
Piotroski F-Score 2